Novonix (NVX) Payables (2020 - 2025)

Novonix (NVX) has reported Payables for 6 consecutive years, with $75.4 million the latest figure, recorded in Q4 2025.

• Quarterly Payables rose 82.55% year-over-year to $75.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $75.4 million (up 82.55% YoY) and the FY2025 annual result came in at $75.4 million, up 82.55% from the prior year.
• Payables retreated to $75.4 million in Q4 2025 per NVX's latest filing, from $110.7 million in the prior quarter.
• Over the last five years, Payables for NVX reached as high as $110.7 million in Q2 2025 and fell as low as $3.3 million in Q2 2021.
• A 5-year average of $42.1 million and a median of $37.2 million in 2021 frame the typical range for Payables.
• Annual changes were most pronounced in 2022 — Payables slumped 80.89% — and 2023, when it surged 770.72%.
• Year by year, Payables stood at $36.4 million in 2021, then sank by 80.89% to $7.0 million in 2022, then jumped by 393.41% to $34.3 million in 2023, then gained by 20.36% to $41.3 million in 2024, then soared by 82.55% to $75.4 million in 2025.
• According to Business Quant data, Payables over the past three periods registered $75.4 million, $110.7 million, and $41.3 million for Q4 2025, Q2 2025, and Q4 2024 respectively.